ALEXANDRIA, Va., July 28 -- The United States Patent and Trademark Office (USPTO) published about the trademark 'SENGROVII' in its latest official gazette. The trademark application with the serial number 79260642 was filed on May 8, 2019.
Here are the other related details:
Goods and Services: 5 - Pharmaceutical preparations for the treatment of hormonal disorders
International/US Class(es): 5
Mark Drawing Code: 4 - STANDARD CHARACTER MARK
Current Owner(s): Novo Nordisk Health Care AG The Circle 32/38 CH-8058 Zürich CH SWITZERLAND 25 AKTIENGESELLSCHAFT (AG)
Disclaimer: Curated by HT Syndication....